Encompass Health (NYSE:EHC) Issues FY 2025 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 4.670-4.960 for the period, compared to the consensus earnings per share estimate of 4.770. The company issued revenue guidance of $5.8 billion-$5.9 billion, compared to the consensus revenue estimate of $5.8 billion.

Encompass Health Stock Up 1.3 %

Shares of NYSE:EHC opened at $99.86 on Friday. The firm has a market cap of $10.06 billion, a P/E ratio of 22.39, a PEG ratio of 1.18 and a beta of 0.90. Encompass Health has a 52-week low of $72.37 and a 52-week high of $104.55. The business’s 50 day simple moving average is $96.28 and its two-hundred day simple moving average is $95.19. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. As a group, research analysts forecast that Encompass Health will post 4.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. KeyCorp upped their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday. Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Finally, Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. One research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $107.33.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.